Literature DB >> 23963412

Physical activity and physical fitness in lymphoma patients before, during, and after chemotherapy: a prospective longitudinal study.

Nele Vermaete1, Pascal Wolter, Gregor Verhoef, Rik Gosselink.   

Abstract

Fatigue is a common and distressing symptom in cancer patients, especially in lymphoma patients. One hypothesized mechanism in the etiology of fatigue is a vicious circle between fatigue, physical inactivity, and deconditioning. However, the natural evolution of physical activity and physical fitness over the course of treatment is unknown. Therefore, the aim of this longitudinal study was to assess fatigue, physical activity, and physical fitness in lymphoma patients before, during, and after treatment. Fatigue was measured with the EORTC-QLQ-C30, physical activity with an accelerometer, and physical fitness with a maximal incremental cycle ergometer test, 6-min walking distance test, and muscle strength measurements. Differences between the three measurement moments and baseline differences between Hodgkin lymphoma and non-Hodgkin lymphoma, early and advanced disease, were analyzed. Twenty-nine patients were included. Functional exercise capacity and quadriceps force were impaired before the start of treatment (86 ± 15 and 82 ± 16 % of predicted value, respectively). Over the course of treatment, significant declines were found in hemoglobin, quadriceps force, handgrip force, and maximal oxygen uptake, while patients reported more fatigue (p values < 0.016). Fatigue was significantly correlated with hemoglobin (r = -0.49), physical activity (r = 0.81), and physical functioning (r = -0.44). Large interindividual variations were found. The present study partially confirmed the hypothesized vicious circle between fatigue, physical inactivity, and deconditioning. Further research with larger samples and longer follow-up is needed to identify factors associated with individual variation in the evolution of fatigue, physical activity, and physical fitness.

Entities:  

Mesh:

Year:  2013        PMID: 23963412     DOI: 10.1007/s00277-013-1881-3

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  14 in total

Review 1.  Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic training.

Authors:  Anthony F Yu; Lee W Jones
Journal:  Future Cardiol       Date:  2015-08-03

2.  Exercise and Fatigue in Adolescent and Young Adult Survivors of Hodgkin Lymphoma: A Report from the Children's Oncology Group.

Authors:  Catherine Fiona Macpherson; Mary C Hooke; Debra L Friedman; Kristin Campbell; Janice Withycombe; Cindy L Schwartz; Kara Kelly; Jane Meza
Journal:  J Adolesc Young Adult Oncol       Date:  2015-09       Impact factor: 2.223

3.  Factors associated with muscle function in patients with hematologic malignancies undergoing chemotherapy.

Authors:  Takuya Fukushima; Jiro Nakano; Shun Ishii; Ayumi Natsuzako; Shuntaro Sato; Junya Sakamoto; Yasushi Miyazaki; Minoru Okita
Journal:  Support Care Cancer       Date:  2019-07-03       Impact factor: 3.603

Review 4.  Effects of exercise interventions for physical fitness, fatigue, and quality of life in adult hematologic malignancy patients without receiving hematopoietic stem cell transplantation: a systematic review and meta-analysis.

Authors:  Wenkui Xu; Lei Yang; Ying Wang; Xiaoxia Wu; Yong Wu; Rong Hu
Journal:  Support Care Cancer       Date:  2022-04-13       Impact factor: 3.359

Review 5.  Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.

Authors:  Jawed A Siddiqui; Ramesh Pothuraju; Maneesh Jain; Surinder K Batra; Mohd W Nasser
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-03-25       Impact factor: 10.680

6.  Evaluation of indices for predicting recovery of exercise tolerance in patients surviving allogenic hematopoietic stem cell transplantation.

Authors:  Ryota Hamada; Tadakazu Kondo; Kazuhiro Harada; Masanobu Murao; Junsuke Miyasaka; Michiko Yoshida; Honami Yonezawa; Manabu Nankaku; Yasuyuki Arai; Junya Kanda; Akifumi Takaori-Kondo; Ryosuke Ikeguchi; Shuichi Matsuda
Journal:  Support Care Cancer       Date:  2022-01-22       Impact factor: 3.603

Review 7.  Health-related quality of life in Hodgkin lymphoma: a systematic review.

Authors:  Nadine Linendoll; Tully Saunders; Rebecca Burns; Jonathan D Nyce; Kristen B Wendell; Andrew M Evens; Susan K Parsons
Journal:  Health Qual Life Outcomes       Date:  2016-07-29       Impact factor: 3.186

Review 8.  Cancer-induced muscle wasting: latest findings in prevention and treatment.

Authors:  Zaira Aversa; Paola Costelli; Maurizio Muscaritoli
Journal:  Ther Adv Med Oncol       Date:  2017-03-08       Impact factor: 8.168

9.  Cancer-Related Fatigue and Muscle Quality in Hodgkin's Lymphoma Survivors.

Authors:  Filipe Dinato de Lima; Martim Bottaro; Ritielli de Oliveira Valeriano; Lorena Cruz; Claudio L Battaglini; Carlos Alexandre Vieira; Ricardo Jacó de Oliveira
Journal:  Integr Cancer Ther       Date:  2017-06-15       Impact factor: 3.279

10.  Physical function in patients newly diagnosed with multiple myeloma; a Danish cohort study.

Authors:  Rikke Faebo Larsen; Mary Jarden; Lisbeth Rosenbek Minet; Ulf Christian Frølund; Sören Möller; Niels Abildgaard
Journal:  BMC Cancer       Date:  2020-03-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.